Featured Research

from universities, journals, and other organizations

Study Calls For 'As Soon As Possible' Treatment Standard For Heart Attack Patients

Date:
May 25, 2009
Source:
BMJ-British Medical Journal
Summary:
Once in hospital, heart attack patients should be treated without delay to cut their risk of death, ideally within even less than the 90 minutes currently recommended by clinical guidelines, say researchers.

Once in hospital, heart attack patients should be treated without delay to cut their risk of death, ideally within even less than the 90 minutes currently recommended by clinical guidelines, say researchers in a paper published on the British Medical Journal website.

After a heart attack, patients often undergo a procedure using a balloon-tipped catheter that is inserted into a main artery, pushed into the narrowed coronary artery, and inflated to clear the blockage. This is called primary percutaneous coronary intervention, or more simply balloon angioplasty.

The time between a patient's arrival at hospital and first balloon inflation is known as the "door-to-balloon time." The current target is 90 minutes, but the benefits of reducing this time even further is still unclear.

So researchers based in the United States set out to investigate the association between door-to-balloon time and deaths in hospital among patients undergoing balloon angioplasty after a heart attack.

They analysed data for 43,801 patients from the American College of Cardiology National Cardiovascular Data Registry. All patients underwent balloon angioplasty within 12 hours of a heart attack at a United States acute care hospital between 2005 and 2006.

Average door-to-balloon time was 83 minutes, with over half of patients (58%) treated within 90 minutes of admission. Overall in-hospital mortality was 4.6%. A greater proportion of patients who had longer door-to-balloon times were women, non-white, and, on average, older than patients with shorter door-to-balloon times. They also had more comorbidities (other disorders, such as diabetes and high blood pressure) than patients with shorter door-to-balloon times.

After adjusting for factors that may have affected the results, longer door-to-balloon times were associated with a higher risk of in-hospital mortality. For example, 3% of patients with door-to-balloon times of 30 minutes died in hospital, while 4.3% of patients with door-to-balloon times of 90 minutes died. The highest mortality rate (10.3%) was for patients with door-to-balloon times of 270 minutes.

These results indicate that any delay in door-to-balloon time for heart attack patients undergoing balloon angioplasty is associated with higher mortality, even among patients treated within 90 minutes of admission, say the authors.

"Rather than accepting the 90 minute door-to-balloon time benchmark, our data support calls for an 'as soon as possible' standard for patients undergoing primary percutaneous coronary intervention. Such an approach, using necessary safeguards against inappropriate treatment, offers the potential for notable mortality reduction," they conclude.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Study Calls For 'As Soon As Possible' Treatment Standard For Heart Attack Patients." ScienceDaily. ScienceDaily, 25 May 2009. <www.sciencedaily.com/releases/2009/05/090519214948.htm>.
BMJ-British Medical Journal. (2009, May 25). Study Calls For 'As Soon As Possible' Treatment Standard For Heart Attack Patients. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2009/05/090519214948.htm
BMJ-British Medical Journal. "Study Calls For 'As Soon As Possible' Treatment Standard For Heart Attack Patients." ScienceDaily. www.sciencedaily.com/releases/2009/05/090519214948.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins